Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Nov 15;73(22):1859-1868.
doi: 10.2146/ajhp150849.

Participation of a coordinating center pharmacy in a multicenter international study

Jihyun Esther Jeon  1 , Janet Mighty  2 , Karen Lane  3 , Nichol McBee  3 , Ryan Majkowski  3 , Steven Mayo  4 , Daniel Hanley  3
Affiliations
Randomized Controlled Trial

Participation of a coordinating center pharmacy in a multicenter international study

Jihyun Esther Jeon et al. Am J Health Syst Pharm. .

Abstract

Purpose: The activities of a coordinating center pharmacy (CCP) supporting a multicenter, international clinical trial are described.

Summary: Serving in a research support role comparable to that of a commercial clinical trial supply company, a CCP within the Johns Hopkins Hospital Investigational Drug Service (JHH IDS) uses its management expertise and infrastructure to support multicenter trials, such as the recently completed Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage, Phase III (CLEAR III) trial. The role of the CCP staff in supporting the CLEAR III trial was overall investigational product (IP) management through coordination of IP-related operations to ensure high-quality care for study participants at study sites in the United States and abroad. For the CLEAR III trial, the CCP coordinated IP supply activities; provided education to site pharmacists; developed study-specific documents, including pharmacy manuals; communicated with trial stakeholders, including third-party IP distributors; monitored treatment assignments; and performed quality assurance monitoring to ensure compliance with institutional, state, federal, and international regulations regarding IP procurement and storage. Acting as a CCP for a multicenter international study poses a number of operational challenges while providing opportunities for the CCP to contribute to research of global importance and enrich the skill sets of its personnel.

Conclusion: The development and implementation of the CCP at JHH IDS for the CLEAR III trial included several responsibilities, such as IP supply management, communication, and database, regulatory, and finance management.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Schema of Coordinating Center Pharmacy, showing the interactions among relevant parties
See this image and copyright information in PMC

References

    1. National Institute of Neurological Disorders and Stroke. NINDS Glossary of Clinical Research Terms. http://www.ninds.nih.gov/research/clinical_research/basics/glossary.htm (accessed 2015 August 15)
    1. Johns Hopkins Medicine. Coordinating Center Functions and Multi-Site Studies. http://www.hopkinsmedicine.org/institutional_review_board/guidelines_pol... (accessed 2015 August 9)
    1. Food and Drug Administration. CFR - Code of Federal Regulations Title 21. 21CFR312.6 Labeling of an investigational new drug. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr... (accessed 2015 August 9)
    1. European Commission. Clinical Trials Directive 2001/20/EC. http://ec.europa.eu/health/human-use/clinical-trials/directive/index_en.htm (accessed 2015 September 16)
    1. The Commission of the European Communities. Commission Directive 2003/94/EC. Good Manufacturing Practice In Respect of Medicinal Products for Human Use and Investigational Medicinal Products for Human Use. 2013; Office Journal of the European Union L 262/22

Publication types

MeSH terms

Substances